ELMD
Electromed, Inc.
ELMD's fundamentals are strong and it looks cheap: trading at 18x earnings, below its usual 32x.
ELMD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
ELMD's revenue, profitability, cash flow and balance sheet are all currently healthy.
ELMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $24.97 | — |
| Cheap | 25x | $34.57 | +38% |
| Fair | 31x | $43.15 | +73% |
| Expensive | 44x | $60.28 | +141% |
Historical ranges are pointers, not guarantees.
ELMD's PE is in its cheap range at 18x.
ELMD Forward outlook
There aren't enough analyst estimates for ELMD to show an outlook.
ELMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.37 | +46% |
| Q2 2026 | $1.30 | +53% |
| Q1 2026 | $1.18 | +49% |
| Q4 2025 | $1.04 | +39% |
| Q3 2025 | $0.94 | +31% |
| Q2 2025 | $0.85 | +47% |
| Q1 2025 | $0.79 | +58% |
| Q4 2024 | $0.75 | +67% |
ELMD's earnings per share have climbed steadily: $1.37 over the past year, up 46% from the year before, and higher year over year for 15 quarters in a row.
ELMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7M | +11% |
| Q2 2026 | $19.4M | +12% |
| Q1 2026 | $18.6M | +18% |
| Q4 2025 | $18.9M | +16% |
| Q3 2025 | $16.9M | +15% |
| Q2 2025 | $17.4M | +17% |
| Q1 2025 | $15.7M | +13% |
| Q4 2024 | $16.3M | +19% |
ELMD's revenue has grown year over year every quarter since late 2020: $19M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | +2.9 points |
| Q2 2026 | 20% | +2.2 points |
| Q1 2026 | 20% | +6.6 points |
| Q4 2025 | 19% | +3.5 points |
| Q3 2025 | 16% | +2.6 points |
| Q2 2025 | 17% | +1.7 points |
| Q1 2025 | 14% | +0.4 points |
| Q4 2024 | 16% | -0.9 points |
ELMD's operating margin was 19% last quarter, up 2.9 points from the same quarter a year ago.
ELMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $208K | +$291K |
| Q2 2026 | $2.8M | -25% |
| Q1 2026 | $3.3M | +49% |
| Q4 2025 | $2.4M | -18% |
| Q3 2025 | -$83K | -104% |
| Q2 2025 | $3.7M | -17% |
| Q1 2025 | $2.2M | +76% |
| Q4 2024 | $2.9M | -14% |
ELMD generated $9M in free cash flow over the past year, about the same as the year before.
ELMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +72.8K shares |
| 1 year | +0.9% | +79.7K shares |
| 3 years | -0.2% | -21.4K shares |
| 5 years | -1.4% | -123K shares |
| Available history | 0% | +2.3K shares |
ELMD has 9M diluted shares, up 0.9% from a year ago, despite $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.3M |
| Q2 2026 | — |
| Q1 2026 | $152,000 |
| Q4 2025 | $2.8M |
| Q3 2025 | $1M |
| Q2 2025 | $3.7M |
| Q1 2025 | $1.8M |
| Q4 2024 | — |
ELMD spent $7M buying back its own shares over the past year, up 12% from the year before.
ELMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -1.7x | Net Cash |
ELMD has more cash than debt.
ELMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.8 | Neutral |
| Stochastic | 7.0 | Oversold |
ELMD's weekly RSI is 36 (neutral) and its Stochastic is 7 (oversold).
ELMD PE vs Healthcare Sector
| Metric | ELMD | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 26x | 29% below |
| PE % | 1 | 29 | 28 pts below |
ELMD is trading at 18x earnings, a 29% discount to the Healthcare sector's median of 26x.
ELMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.1 | 7.8% below |
| 20 week MA | $33.2 | 25% below |
| 50 week MA | $30.7 | 19% below |
| 100 week MA | $27.5 | 9.3% below |
| 200 week MA | $20.9 | 20% above |
ELMD has fallen below most of its moving averages, though it's still 20% above its 200-week average.
ELMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.57 | $9.99 | +17% |
| 2021 | $9.99 | $12.7 | +27% |
| 2022 | $12.7 | $9.89 | -22% |
| 2023 | $9.89 | $10.9 | +10% |
| 2024 | $10.9 | $29.2 | +168% |
| 2025 | $29.2 | $28.5 | -2.5% |
| 2026 YTD | $28.5 | $25.0 | -12% |
ELMD has finished higher in four of the last six years. It's down 12% so far in 2026.